Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.

Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.

Item

http://www.wikidata.org/entity/Q47712533

Q47712533

about

Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.

Item

http://www.wikidata.org/entity/Q47712533

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Modification of structural les ...... aphic axial spondyloarthritis.

@en

Modification of structural les ...... aphic axial spondyloarthritis.

@nl

type

Item

label

Modification of structural les ...... aphic axial spondyloarthritis.

@en

Modification of structural les ...... aphic axial spondyloarthritis.

@nl

prefLabel

Modification of structural les ...... aphic axial spondyloarthritis.

@en

Modification of structural les ...... aphic axial spondyloarthritis.

@nl

P1476

Modification of structural les ...... aphic axial spondyloarthritis.

@en

P2093

Annette Szumski

http://www.w3.org/2001/XMLSchema#string

Heather E Jones

http://www.w3.org/2001/XMLSchema#string

Jack F Bukowski

http://www.w3.org/2001/XMLSchema#string

Lisa Marshall

http://www.w3.org/2001/XMLSchema#string

Robert G Lambert

http://www.w3.org/2001/XMLSchema#string

Ron Pedersen

http://www.w3.org/2001/XMLSchema#string

Stephanie Wichuk

http://www.w3.org/2001/XMLSchema#string

P2860

Metric Properties of the SPARCC Score of the Sacroiliac Joints - Data from Baseline, 3-month, and 12-month Followup in the SPACE Cohort.

Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis

Tumor necrosis factor inhibitor therapy but not standard therapy is associated with resolution of erosion in the sacroiliac joints of patients with axial spondyloarthritis.

Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48.

Combining information obtained from magnetic resonance imaging and conventional radiographs to detect sacroiliitis in patients with recent onset inflammatory back pain

Can erosions on MRI of the sacroiliac joints be reliably detected in patients with ankylosing spondylitis? - A cross-sectional study.

Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group.

Good correlation between changes in objective and subjective signs of inflammation in patients with short- but not long duration of axial spondyloarthritis treated with tumor necrosis factor-blockers.

Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years.

MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis.

P304

78-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ANNRHEUMDIS-2017-211605

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maxime Dougados

Walter P Maksymowych

P577

2017-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28970212

http://www.w3.org/2001/XMLSchema#string

P921

placebo

P932

5754741

http://www.w3.org/2001/XMLSchema#string

Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.

about

Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932